Analgesic Efficacy of Different Doses of Sucrose During Blood Sampling in Preterm Infants
1 other identifier
interventional
144
1 country
1
Brief Summary
The objective of this trial is to compare the analgesic effect of a single dose of oral sucrose 24% administered two minutes before a blood sampling (either heel prick or vascular puncture) versus multiple doses of oral sucrose 24% administered two minutes before and during the procedure in a population of preterm newborns of Gestational Age ≤ 36+6 weeks hospitalized in Neonatal Intensive Care Unit, using neonatal pain scales (Premature Infant Pain Profile (PIPP), Face, Legs, Activity, Cry, Consolability (FLACC) and indirect Visual Analogue Scale (VAS)) and Skin Conductance (SC) measurement (Pain Monitor).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2015
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedFirst Posted
Study publicly available on registry
August 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedAugust 9, 2016
August 1, 2016
10 months
December 16, 2015
August 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of analgesic efficacy Premature Infant Pain Profile (PIPP)
The primary outcome of this study will be to evaluate the analgesic efficacy of sucrose 24% administration (single versus multiple doses) during blood sampling using Premature Infant Pain Profile (PIPP).
2 minutes before, at the moment of the skin puncture, and at 30, 60 and 120 seconds after the skin puncture
Secondary Outcomes (25)
Change of analgesic efficacy Face, Legs, Activity, Cry, Consolability (FLACC)
at 30 and 120 seconds after the skin puncture
Change of analgesic efficacy Visual Analogue Scale (VAS)
at 30 and 120 seconds after the skin puncture
Change of analgesic efficacy Pain Monitor (skin electrical conductance)
2 minutes before, at the moment of the skin puncture, and at 30, 60 and 120 seconds after the skin puncture
Pain evaluation during heel prick Vs vascular puncture PIPP
Through study completion, an average of 1 year
Pain evaluation during heel prick Vs vascular puncture FLACC
Through study completion, an average of 1 year
- +20 more secondary outcomes
Study Arms (2)
sucrose24% 2 minutes before
ACTIVE COMPARATORsucrose 24% 0,3 mL if \< 1000 g or 0,5 mL if \> 1000 g two minutes BEFORE the skin breaking procedure
sucrose24% 2minutes before and during
EXPERIMENTALsucrose 24% 0,3 mL if \< 1000 g or 0,5 mL if \> 1000 g two minutes BEFORE and DURING the skin breaking procedure
Interventions
Premature neonates undergoing blood samples through skin breaking procedures, meeting inclusion criteria, will be randomized as soon as the doctor decision to drown the blood is made, to either sucrose 24% 0,3 mL if \< 1000 g or 0,5 mL if \> 1000 g two minutes BEFORE the skin breaking procedure or sucrose 24% 0,3 mL if \< 1000 g or 0,5 mL if \> 1000 g two minutes BEFORE and DURING the skin breaking procedure, according to a computer generated randomization list.
Eligibility Criteria
You may qualify if:
- preterm neonates with gestational age ranging from 23+ 0 to 36+ 6 weeks
- undergoing blood sampling (either heel prick or vascular puncture)
- age ≤ 40 week GA + 28 days at the time of blood sampling
- parental written informed consent for participation in the study must be obtained
You may not qualify if:
- Evidence of severe birth asphyxia, that is an APGAR score below 5 at 5 minutes of age and/or umbilical arterial pH \< 7.0
- Known genetic or chromosomal disorders
- Myopathies and neuropathies interfering with pain assessment by pain scales
- Sedation
- Presence of central catheter allowing blood sampling without skin breaking
- Other painful procedure less than 2 hours before blood sampling
- Physiological instability (more than 6 episodes of bradycardia and/or apnea per day)
- Maternal drug abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Padova
Padua, Padova, 35128, Italy
Related Publications (6)
Cignacco EL, Sellam G, Stoffel L, Gerull R, Nelle M, Anand KJ, Engberg S. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics. 2012 Feb;129(2):299-308. doi: 10.1542/peds.2011-1879. Epub 2012 Jan 9.
PMID: 22232305BACKGROUNDShah PS, Herbozo C, Aliwalas LL, Shah VS. Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004950. doi: 10.1002/14651858.CD004950.pub3.
PMID: 23235618BACKGROUNDSimonse E, Mulder PG, van Beek RH. Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics. 2012 Apr;129(4):657-63. doi: 10.1542/peds.2011-2173. Epub 2012 Mar 5.
PMID: 22392168BACKGROUNDYin T, Yang L, Lee TY, Li CC, Hua YM, Liaw JJ. Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. Int J Nurs Stud. 2015 Aug;52(8):1288-99. doi: 10.1016/j.ijnurstu.2015.04.012. Epub 2015 Apr 23.
PMID: 25939641BACKGROUNDShah VS, Ohlsson A. Venepuncture versus heel lance for blood sampling in term neonates. Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD001452. doi: 10.1002/14651858.CD001452.pub4.
PMID: 21975734BACKGROUNDStevens B, Yamada J, Lee GY, Ohlsson A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD001069. doi: 10.1002/14651858.CD001069.pub4.
PMID: 23440783BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paola Lago, MD
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 16, 2015
First Posted
August 9, 2016
Study Start
February 1, 2016
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
August 9, 2016
Record last verified: 2016-08